Scientists at the University of Edinburgh are developing multiplex microarray assays to accelerate routine blood typing and diagnosis of infectious diseases, using Tecan’s LS Reloaded™ laser scanner ...

Mass Spec Alternative Detects Biomarker Signatures in Tissues, Blood, and Cell Culture The current generation of antibody microarray technologies is providing highly sensitive new tools for screening ...

Processes Involved in Using DNA Microarray Instrumentation in Protein Microarray Workflow Protein microarrays offer the ability to measure protein expression and antibody binding in a high-throughput ...

EYSINS, Switzerland, April 3, 2025 /PRNewswire/ --Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® ...

Farmington, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The Global Microarrays Market size was estimated at USD 3.72 Billion in 2022 and is expected to surpass USD 8.15 Billion by 2030, expanding at a CAGR of 8 ...

PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely DetectX, EnviroX, and QuantX SANTA CLARA, ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx ...

The Genotyping Assay Market refers to the industry segment that develops and offers assays, kits, platforms, and services for determining genetic variations among individuals, including single ...

EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ -- AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® Celiac ...